UNSPSC 51101646: Chlorbetamide

This classification denotes an antiprotozoal agent with the molecular formula C11H11Cl4NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3S489RFX0J, chemically known as 2,2-dichloro-n-2,4-dichlorobenzyl-n-2-hydroxyethyl-acetamide but generally known as chlorbetamide, which bears US NIH Compound Identifier 7330. European Medicines Agency schedules Chlorbetamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06177MIG.

UNSPSC 51101646 Chlorbetamide is a Commodity code that does not reflect the pharmaceutical products and medical supplies actually being solicited by state and local governments under this classification. The recent opportunities tagged to this code show little relevant activity to the Chlorbetamide scope; instead, they describe procurement of naloxone, doxycycline hyclate, ciprofloxacin hydrochloride, and safe drug deactivation systems—products unrelated to chlorbetamide. This mismatch suggests either a classification error in the state and local procurement systems or that the code is not actively used to describe the pharmaceutical commodities state and local agencies are currently sourcing.

Activity under this code spans state health departments and county governments. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for doxycycline hyclate and ciprofloxacin hydrochloride with a three-year total contract value of $2,999,999.11; Seminole County, Florida issued an IFB on June 30, 2026, for naloxone and safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. No open solicitations under this code are currently active for response. Given the lack of recent opportunities aligned with the chlorbetamide commodity scope, this code does not present a clear procurement pathway for business development at this time.